Vivo Bio Tech Limited (VIVOBIOT.BO)
INR 40.64
(11.8%)
INR 40.64
(11.8%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 212.99 Million INR | -1.9% |
| 2022 | 218.72 Million INR | 35.33% |
| 2021 | 161.88 Million INR | -10.29% |
| 2020 | 178.85 Million INR | -13.01% |
| 2019 | 203.93 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 43.64 Million INR | -18.65% |
| 2023 Q1 | 44.85 Million INR | -37.28% |
| 2023 Q4 | 53.79 Million INR | -16.04% |
| 2023 Q3 | 64.06 Million INR | 31.88% |
| 2023 FY | - INR | -1.9% |
| 2023 Q2 | 48.58 Million INR | 8.3% |
| 2022 FY | - INR | 35.33% |
| 2022 Q4 | 71.51 Million INR | 44.97% |
| 2022 Q3 | 49.32 Million INR | 5.63% |
| 2022 Q1 | 47.83 Million INR | 229.54% |
| 2022 Q2 | 46.7 Million INR | -2.37% |
| 2021 Q2 | 27.97 Million INR | -52.65% |
| 2021 Q1 | 59.08 Million INR | 67.45% |
| 2021 Q3 | 57.54 Million INR | 105.71% |
| 2021 Q4 | 14.51 Million INR | -74.78% |
| 2021 FY | - INR | -10.29% |
| 2020 Q3 | 47.84 Million INR | -20.09% |
| 2020 Q2 | 59.87 Million INR | 107.45% |
| 2020 Q1 | 28.86 Million INR | 4296.0% |
| 2020 FY | - INR | -13.01% |
| 2020 Q4 | 35.28 Million INR | -26.25% |
| 2019 Q4 | 656.55 Thousand INR | -98.27% |
| 2019 FY | - INR | 0.0% |
| 2019 Q3 | 37.93 Million INR | 2.56% |
| 2019 Q1 | 37.77 Million INR | 405.07% |
| 2019 Q2 | 36.98 Million INR | -2.09% |
| 2018 Q4 | -12.38 Million INR | -138.28% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 39.07 Million INR | 0.0% |
| 2018 Q3 | 32.34 Million INR | -17.22% |
| 2017 Q1 | 24.49 Million INR | 55.05% |
| 2017 Q4 | 26.64 Million INR | -15.79% |
| 2017 Q3 | 31.64 Million INR | 15.63% |
| 2017 Q2 | 27.36 Million INR | 11.72% |
| 2016 Q1 | 14.48 Million INR | 48.78% |
| 2016 Q4 | 15.79 Million INR | -37.73% |
| 2016 Q3 | 25.36 Million INR | 3.12% |
| 2016 Q2 | 24.6 Million INR | 69.82% |
| 2015 Q3 | 10.08 Million INR | -21.0% |
| 2015 Q4 | 9.73 Million INR | -3.43% |
| 2015 Q1 | 13.41 Million INR | -33.58% |
| 2015 Q2 | 12.76 Million INR | -4.86% |
| 2014 Q4 | 20.19 Million INR | 186.98% |
| 2014 Q1 | 3.86 Million INR | -42.99% |
| 2014 Q2 | -3.12 Million INR | -180.86% |
| 2014 Q3 | 7.03 Million INR | 325.43% |
| 2013 Q4 | 6.77 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 36.55 Million INR | -482.633% |
| Checkpoint Trends Limited | 297.07 Thousand INR | -71599.936% |
| Everest Organics Limited | 118.72 Million INR | -79.402% |
| GUJARAT INJECT (KERALA) LTD. | 1.05 Million INR | -20134.955% |
| NATURO INDIABULL LIMITED | 14.68 Million INR | -1350.255% |
| NEXUS SURGICAL AND MEDICARE LI | 2.98 Million INR | -7042.975% |
| Rajnish Wellness Limited | 19.93 Million INR | -968.253% |
| Rama Vision Limited | 67.79 Million INR | -214.19% |